LinkedIn
YouTube
Instagram
Contact Us
1-800-850-9132
Log In
#KidneyCancer
@KidneyCancer

YOU MATTER.
WE CARE.
YOU ARE NOT ALONE.

ACCESS INFORMATION & LITERATURE
JOIN NOW
ABOUT DISEASE TREATMENT
GET INFORMATION
SUPPORT RESEARCH
MAKE A DONATION

Upcoming Events

FIND MORE

Publications

NCCN GUIDELINES FOR PATIENTS

Kidney Cancer

DOWNLOAD BOOK
WE HAVE

Kidney Cancer

DOWNLOAD BOOK
VIEW ALL PUBLICATIONS
0
%

5-Year Survival Rate Percentage increase from 2007 through 2013

0

Estimated new cases in the US, this year

0

Estimated Deaths in the US, this year

0

People are living with kidney and renal pelvis cancer, according to NCI SEER data from 2014

Evaluate your treatment options and make decisions

From the Pressroom

News from Kidney Cancer Association This feed has been created by Kidney Cancer Association

  • Trials Presented at ESMO 2018
    on November 14, 2018 at 4:31 pm

    In patients with previously untreated advanced renal cell carcinoma (RCC) whose tumors were positive for the PD-L1 checkpoint, a combination of the checkpoint inhibitor avelumab and the tyrosine kinase inhibitor (TKI) axitinib increased the median PFS from 8.4 months to 13.8 months when compared […]

  • Phase 1 study of everolimus and low-dose oral...
    on November 14, 2018 at 4:24 pm

    mTOR inhibitors are frequently used in the treatment of metastatic renal cell cancer (mRCC). mTOR regulates cell growth, proliferation, angiogenesis, and survival, and additionally plays an important role in immune regulation. Since mTOR inhibitors were shown to benefit immunosuppressive regulatory […]

  • CIP2A Promotes Proliferation, Invasion and...
    on November 14, 2018 at 4:21 pm

    CIP2A is a well-known oncoprotein whose expression is elevated in multiple human solid tumor types. However, its role in renal cell carcinoma (RCC) development is poorly understood.11/14/2018 […]

More from the Press Room

YOU MATTER.
WE CARE.
YOU ARE NOT ALONE.

DONATE NOW

  Kidney Cancer Association

Kidney Cancer Association

The Kidney Cancer Association (KCA) is a charitable organization made up of patients, family members, physicians, researchers, and other health professionals globally. It is the world’s first international charity dedicated specifically to the eradication of death and suffering from renal cancers.
Kidney Cancer Association
Kidney Cancer Association2 days ago
Dr. Jim Allison, winner of the 2018 Nobel Prize for Physiology or Medicine said future cancer research will have a large focus on combining immunotherapy with targeted drugs. “We now know it works… and so it’s something out there that can offer patients a bit of hope,” Dr. Allison says.
Kidney Cancer Association
Nobel Prize Winner: What's Next For Using Immunotherapy to Save Lives | SurvivorNet
The 2018 Nobel Prize winner for Physiology or Medicine, Dr. Jim Allison, explains immunotherapy combinations and how they can say lives.
survivornet.com
10    View on Facebook
Kidney Cancer Association
Kidney Cancer Association3 days ago
Attention Medical Professionals: Registration for our 14th Annual European International Kidney Cancer Symposium is now open! Please use this link to register: https://bit.ly/2B9vKMM
#EIKCS19
Kidney Cancer Association
102 10    View on Facebook
Kidney Cancer Association
Kidney Cancer Association4 days ago
#KidneyCancerNews: A clinical trial at UT Southwestern saved the life of a man diagnosed with stage 4 kidney cancer.
Kidney Cancer Association
Clinical Trial Saves Life of Stage 4 Kidney Cancer Patient
When a well-known journalist in Dallas learned he had stage four kidney cancer, he was told he had three, possibly four, years to live. Now, the tumor threatening his life is gone thanks to a clinical cancer...
nbcdfw.com
129 11    View on Facebook

  #KidneyCancer

  kidneycancerassociation

3 days ago
  • 12
  • 1
4 days ago
  • 16
  • 0
6 days ago
  • 22
  • 0

  Kidney Cancer

Menu